To access this work you must either be on the Smith College campus OR have valid Smith login credentials.
On Campus users: To access this work if you are on campus please Select the Download button.
Off Campus users: To access this work from off campus, please select the Off-Campus button and enter your Smith username and password when prompted.
Non-Smith users: You may request this item through Interlibrary Loan at your own library.
Publication Date
2025-5
First Advisor
Maren E. Buck
Second Advisor
Sarah J. Moore
Document Type
Honors Project
Degree Name
Bachelor of Arts
Department
Engineering
Keywords
polymer chemistry, bioengineering, regenerative medicine, drug conjugates, hydrogel scaffolds
Abstract
Polyethylene glycol (PEG) has long been considered the preferred polymer for use in pharmaceutical drugs and biomedical scaffolds. Its highly hydrophilic polyether backbone enhances its solubility in water, making it more biocompatible. However, its simple structure limits the chemistry that can be done with PEG and its derivatives, hence restricting its versatility and use in a wider range of applications. It was also proven to be immunogenic in individuals with pre-existing PEG antibodies, consequently impacting drug efficacy and safety. For these reasons, more versatile and functional polymers are needed for improved outcomes. This thesis project aims to exploit the versatility of an azlactone-based polymer, referred to as poly(2-vinyl-4,4’-dimethyl azlactone) (PVDMA), for applications in targeted drug delivery and tissue engineering. In one aim of this thesis, PVDMA was successfully fabricated for potential applications in targeted drug-delivery. By synthezing the polymer with varying chain lengths and grafting to the engineered protein, Fn3-RGD, protein-polymer conjugates (PPCs) are formed. These particles can bind to ɑv3 integrin receptors expressed on neovasculature in tumors and on numerous cancer cells, such as on brain cancer cells. The conjugates were successfully formed 24 hours post-conjugation, and the polymer chains could be differentiated with respect to their sizes using size-exclusion chromatography (SEC). The second goal of my thesis sought to develop azlactone-based gels for applications in tissue engineering. PVDMA was crosslinked with Jeffamine-600, another biocompatible polymer, to form hydrogel layers of varying porosity levels. Individual hydrogel layers were characterized through FTIR spectroscopy, swelling analysis, and mechanical testing. The PVDMA-Jeffamine 600 crosslinked gel layers were then superimposed and swelled in solvent to induce differential swelling and force the gel to mimic tubular structures in the body. This design was reiterated multiple times to determine the design’s optimal conditions and maximize its self-rolling behavior. Waiting time between hydrogel casting and 2D aspect ratio were variables found to be particularly relevant, with a waiting time shorter than 1 hour and a 1:2 aspect ratio being the most optimal conditions. RGD peptides were also used to functionalize the inner surface of the tubes to improve cell adhesion, and its hydrophobic nature was found to amplify differential swelling and strengthen self-rolling behavior.
Rights
©2025 Karen Bekhazi. Access limited to the Smith College community and other researchers while on campus. Smith College community members also may access from off-campus using a Smith College log-in. Other off-campus researchers may request a copy through Interlibrary Loan for personal use.
Language
English
Recommended Citation
Bekhazi, Karen, "Design of Reactive Azlactone Biomaterials for Applications in Targeted-Drug Delivery and Tissue Engineering" (2025). Honors Project, Smith College, Northampton, MA.
https://scholarworks.smith.edu/theses/2766
Smith Only:
Off Campus Download

Comments
140 pages: color illustrations, charts. Includes bibligraphical references (pages 129-132).